The more the industry evolves, the more compliance teams need to keep pace with this change. The good news is there are 6 actionable steps you can make to stay ahead of the dynamic pressure.
Through our lens into real-world issues that affect equitable use of industry innovations, Medical Affairs can drive the transformation of industry from a drug-centric perspective to a patient-centric perspective. This article discusses a few of these opportunities.
Omnichannel communication is the strategy of integrating various communication channels, both digital and non-digital, and joining multiple communication touchpoints to provide a seamless, personalized experience, and unified identity across all channels, devices, and touchpoints: the customer (namely HCPs and patients), rather than the product, is at the center.
Health literacy is experiencing new challenges, and Medical Affairs is uniquely positioned to lead and partner with others in this space to ensure coordination, credibility and impact.
Health literacy is experiencing new challenges, and Medical Affairs is uniquely positioned to lead and partner with others in this space to ensure coordination, credibility and impact.
10 reasons digital strategies fail plus ways you and your teams can navigate between the icebergs of these failures on the way to success.
This MAPS Executive Consortium article explores ways in which Medical Affairs can help industry adapt its practices to deal with emerging issues in the transition to personalized medicine.
The authors present planning, process, compliance, and copyright considerations for both author- and sponsor-led publication enhancers.
The MAPS Executive Consortium details how Medical Affairs will drive the evolution of industry to match the needs of a changing society.
“I see Medical Affairs co-leading the pharmaceutical and MedTech industries into a new era of patient-centered evidence generation and communication in a valued-based world,” Kremer says.